Jason Assad
Investor Relations
Replay available
Item 9 Labs Corp (OTC: INLB) Q3 2022 earnings conference call, held 2022-08-16. Replay captured from the company's public earnings webcast.

Investor Relations
Chief Executive Officer
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Item 9 Labs Corp..
WEBVTT 00:00:00.029 -- 00:00:03.170 This is Jason Assad with Investor Relations with Item 9 Labs. 00:00:03.170 -- 00:00:06.991 Good morning and welcome to Item 9 Labs Fiscal 00:00:07.171 -- 00:00:12.122 Q3 2022 Results Conference Call for the three months ended June 30th, 2022. 00:00:12.373 -- 00:00:16.795 Joining me on the call today are Chief Executive Officer Andrew Bowden and our Chief 00:00:16.795 -- 00:00:22.117 Financial Officer Bobby Mikkelsen. Shortly before this call, we filed our Form 10-Q, 00:00:22.117 -- 00:00:26.397 a copy of which are available on the company's website at item9labscorp.com. 00:00:26.938 -- 00:00:29.568 I'll start today by reading the Safe Harbor Statement. 00:00:29.568 -- 00:00:33.291 The statement is made pursuant to the safe harbor for forward-looking statements described 00:00:33.291 -- 00:00:37.233 in the Private Securities Litigation Reform Act of 1995. 00:00:37.233 -- 00:00:41.276 All statements made in this call, with the exception of historic facts, may be considered 00:00:41.276 -- 00:00:45.476 forward-looking statements within the meaning of Section 27A of the Securities Act of 00:00:45.476 -- 00:00:50.529 1933 and Section 21E of the Securities Act of 1934. 00:00:50.529 -- 00:00:54.491 Although we believe the expectations and assumptions reflected in these forward-looking 00:00:54.491 -- 00:00:58.534 statements are reasonable, we can make no assurances that such expectations will prove 00:00:58.534 -- 00:01:03.417 to be correct. Actual results may differ materially from those expressed or implied in 00:01:03.417 -- 00:01:06.819 forward-looking statements due to various risks and uncertainties. 00:01:06.819 -- 00:01:11.121 For a discussion of such risks and uncertainties that could cause actual results to differ 00:01:11.121 -...